Sidney Rohrscheib, MD
Surgery · Clinton, ILNPI 1073580122
Payments from drug & device makers
Across 66 payments — averaging $566.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reshape Lifesciences Inc.$29K
- Senseonics, Incorporated$7K
- Teleflex LLC$131
- Johnson & Johnson$120
- Novo Nordisk$86
- Olympus America Inc.$70
- plus $416 from 13 others
What the payments were for
- Consulting fees$5001%
- Speaking & faculty fees$35,21894%
- Food & beverage$1,6454%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reshape Lifesciences Inc. | 17 | $29,286 |
| Senseonics, Incorporated | 14 | $7,255 |
| Teleflex LLC | 1 | $131 |
| Johnson & Johnson | 6 | $120 |
| Novo Nordisk | 5 | $86 |
| Olympus America Inc. | 3 | $70 |
| Standard Bariatrics, Inc. | 2 | $65 |
| Medtronic | 3 | $57 |
| Lilly USA, LLC | 2 | $51 |
| Grifols USA, LLC | 2 | $46 |
| Baudax Bio Inc. | 2 | $38 |
| Vertex | 2 | $34 |
| Reprise Biomedical, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Electromed, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| W. L. Gore & Associates, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,364 in reported general payments places this provider in the 90th percentile of 1,180 surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $501 |
Paid to pharmacies, not to this prescriber.
Other surgery in Clinton
- Luis FernandezMaywood$1.8M
- Jaishankar RamanBurr Ridge$1.6M
- Reza GamagamiNew Lenox$1.2M
- Francesco BiancoChicago$1.2M
- Mark KeldahlChicago$765K
- Michael UjikiEvanston$749K
- Barry RosenBarrington$443K
- Douglas JonesChampaign$425K
- Erik BorncampNew Lenox$422K
- Rami LutfiChicago$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.